Answers are grounded in this paper and cite their sources.
Comparison of missense MET TKD defined as “probably pathogenic” and “probably benign” according to three in silico tools. Comparison of (A) secondary structure features, (B) relative solvent accessible surface area (RSA), and (C) mutant amino acid properties of missense MET TKD mutations of unknown biological function according to OncoKB. Mutations were defined as “probably pathogenic” for likely pathogenicity across all three tools and as “probably benign” for likely benign across all three scores. OR: odds ratio; 95% CI: 95% confidence interval.
No takes yet. Share an insight, caveat, or question.
Pecci et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: